Why the study?
Does a valve-in-valve technique using a mechanical prosthesis implanted in a bioprosthetic annulus provide safe and effective outcomes in patients with degenerated mitral bioprostheses?
Does a valve-in-valve technique using a mechanical prosthesis implanted in a bioprosthetic annulus provide safe and effective outcomes in patients with degenerated mitral bioprostheses?
A surgical valve-in-valve technique for degenerated mitral bioprostheses appears feasible, yielding favorable hemodynamics and mid-term survival without serious morbidity in a small initial cohort.
Answers are grounded in this paper and cite their sources.
May support mechanical valve-in-valve for degenerated mitral bioprostheses; leaves open need for prospective validation before practice change.
Mitral valve prosthetic replacement carries high mortality rates by modern standards, and mitral bioprostheses are particularly prone to degeneration. Bioprosthetic replacement may be technically difficult when there is calcification of the tissue ingrowth, strut incorporation, or valve-to-annulus size mismatch at the primary operation. A "valve-in-valve" technique is described where the mechanical prosthesis is implanted in the bioprosthetic annulus in order to avoid such difficulties. The results in the first eight patients are presented, showing post-operative Doppler-derived transvalvar mean gradients between 3.9 mmHg and 7.5 mmHg, and estimated valve areas between 1.9 cm2 and 3.5 cm2. All patients are alive at between 20 and 30 months (mean 23.6 months) after operation, they are without serious post-operative morbidity and are in functional class I or II (NYHA classification).
No takes yet. Share an insight, caveat, or question.
Paterson et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: